The use of biological markers in the diagnosis and follow-up of patients with multiple sclerosis.: Test of the five humours

被引:8
|
作者
Oehninger-Gatti, C [1 ]
Buzó, R [1 ]
Alcántara, JC [1 ]
Chouza, C [1 ]
Gómez, A [1 ]
Cibils, D [1 ]
Gordon-Firing, S [1 ]
机构
[1] Hosp Clin, Neurol Inst, Secc Enfermedades Desmielinizantes, Montevideo, Uruguay
关键词
cerebrospinal fluid; cetrulin rich basic myelin protein of the central nervous system; light chain imbalance; oligoclonal distribution of immunoglobulins multiple sclerosis; soluble interleukin-2 receptor;
D O I
10.33588/rn.3010.99367
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Patients and methods. We studied five biological fluids which were easily accessible to immunological examination (cerebrospinal fluid, plasma tears, saliva and urine) in 25 patients with multiple sclerosis, clinically definite according to the criteria of Cleveland, Ohio (1991) and tabulated according to the Kurztke's expanded disability status scale. The samples were obtained simultaneously during a clinical bout of the disease before any pharmacological or immunosuppressive treatment had been given. Results. The soluble interleukin-2 levels were significantly raised in at least three of these fluid's -always absent from the urine- when compared with normal controls The sensitivity and specificity of this determination for diagnosis of the condition was greater than that of other immunochemical parameters -oligoclonal distribution of immunoglobulins (specifically of IgG), imbalance of the light Kappa and Lambda chains and physiological studies (evoked potentials). The dosification and quantification of basic myelin protein of the central nervous system, rich in citruline in the urine, may be a parameter of progressiveness. Conclusion. This methodology (five humours test) may be used to establish an earlier more certain diagnosis of multiple sclerosis and also monitor its biological activity together with nuclear magnetic resonance with intravenous contrast.
引用
收藏
页码:977 / 979
页数:3
相关论文
共 50 条
  • [21] OSE: A simple tool for the evaluation and follow-up of patients with relapsing-remitting multiple sclerosis. Final results on 227 patients
    Vernay, D.
    Edan, G.
    Moreau, T.
    Visy, J. M.
    Gury, C.
    MULTIPLE SCLEROSIS, 2007, 13 : S216 - S216
  • [22] Inpatient and outpatient rehabilitation in subjects with multiple sclerosis. A prospective and 6 months follow-up study
    Ungaro, D.
    Ciccone, B.
    Judica, E.
    Boneschi, F. Martinelli
    Rossi, P.
    Vivo, P.
    Griso, G.
    Crisci, C.
    Comola, M.
    Comi, G.
    JOURNAL OF NEUROLOGY, 2009, 256 : S31 - S31
  • [23] Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients
    Borriello, Giovanna
    Ianniello, Antonio
    Toosy, Ahmed T.
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (14)
  • [24] Use of serum tumor markers for the diagnosis and follow-up of breast cancer
    Barrenetxea, G
    Schneider, J
    Llorente, MF
    ONCOLOGY, 1998, 55 (05) : 447 - 449
  • [25] Venezuelan consensus guidelines on the use of magnetic resonance in diagnosis and follow up of patients with multiple sclerosis
    Lander, Bernardo
    Alvarado, Mariangela
    Alvarez, Isabel C.
    Armas, Elizabeth
    Chique-Alfonzo, German
    Hernandez, Freda
    Labarca, Rossanny
    Leon, Rosalba
    Molina, Omaira
    Monasterios, Isabel
    Ramirez, Clara I.
    Rubio, Evelio
    Torres, Belen
    Viso-Barroso, Rene
    Simmonds, Zully
    Soto, Arnoldo
    REVISTA DE NEUROLOGIA, 2017, 65 (03) : 117 - 126
  • [26] Biological markers to confirm diagnosis and monitor the therapy in multiple sclerosis patients
    Michalowska-Wender, G
    Losy, J
    Wender, M
    FOLIA NEUROPATHOLOGICA, 2001, 39 (01): : 1 - 5
  • [27] Consensus statement on the use of gadolinium for magnetic resonance imaging (MRI) used in the diagnosis and follow-up of patients with multiple sclerosis (MS)
    Traboulsee, A.
    Oh, J.
    Barlow, L.
    Chan, J.
    Cohen, B.
    Costello, K.
    Halper, J.
    Harris, C.
    Jones, D.
    Kanal, E.
    Li, D.
    Maravilla, K.
    Nelson, F.
    Newsome, S.
    Pelletier, D.
    Rammohan, K.
    Reich, D.
    Rovira, A.
    Stone, L.
    Wolinsky, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 957 - 957
  • [28] Economic impact of selective use of contrast for routine follow-up MRI of patients with multiple sclerosis
    Mattay, Raghav R.
    Davtyan, Karapet
    Rudie, Jeffrey D.
    Mattay, Govind S.
    Jacobs, Dina A.
    Schindler, Matthew
    Loevner, Laurie A.
    Schnall, Mitchell D.
    Bilello, Michel
    Mamourian, Alexander C.
    Cook, Tessa S.
    JOURNAL OF NEUROIMAGING, 2022, 32 (04) : 656 - 666
  • [29] Neuropsychological features in childhood and juvenile multiple sclerosis Five-year follow-up
    Amato, Maria P.
    Goretti, Benedetta
    Ghezzi, Angelo
    Hakiki, Bahia
    Niccolai, Claudia
    Lori, Silvia
    Moiola, Lucia
    Falautano, Monica
    Viterbo, Rosa G.
    Patti, Francesco
    Cilia, Sabina
    Pozzilli, Carlo
    Bianchi, Valentina
    Roscio, Marco
    Martinelli, Vittorio
    Comi, Giancarlo
    Portaccio, Emilio
    Trojano, Maria
    NEUROLOGY, 2014, 83 (16) : 1432 - 1438
  • [30] Cognitive impairment in secondary progressive multiple sclerosis. A longitudinal one-year follow-up study
    Casanova, B
    Andreu, M
    Bueno, A
    Gadea, M
    Escutia, M
    Bernat, A
    Bosca, I
    Coret, F
    JOURNAL OF NEUROLOGY, 2004, 251 : 121 - 121